Welcome to Merz North America

Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the US. Our products are distributed through two divisions: Aesthetics and Neurosciences.

News

FDA Approves XEOMIN® (incobotulinumtoxinA) For Adult Patients with Sialorrhea

Merz North America announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN® (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, in adult patients. XEOMIN is the first and only neurotoxin with this approved indication in the U.S.

Read More

Merz North America Promotes Alana Sine to Chief Financial Officer

Merz North America today announced the appointment of Alana Sine to Chief Financial Officer (CFO), Merz North America. Sine has served as interim CFO since March 2018.

Read More

Merz Products Recognized as Best-In-Class by NewBeauty, THE European Aesthetic Guide and InStyle Magazine

Merz announced today that Ultherapy®, Radiesse® and Cellfina® have been named the best “In-Office Treatments” by NewBeauty Magazine. In addition, Cellfina® was recognized as the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide. Neocutis® Lumière® and Lumière® Riche were named “Best Beauty Buys” by InStyle Magazine...

Read More